Curis Inc. (CRIS)

0.84
NASDAQ : Health Technology
Prev Close 0.80
Day Low/High 0.77 / 0.85
52 Wk Low/High 0.60 / 5.20
Avg Volume 342.30K
Exchange NASDAQ
Shares Outstanding 33.11M
Market Cap 24.94M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Curis Reports Third Quarter 2018 Financial Results

Curis Reports Third Quarter 2018 Financial Results

-- New leadership increasing focus on clinical execution --

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LEXINGTON, Mass., Oct.

Curis To Present At The Cantor Fitzgerald Global Healthcare Conference

Curis To Present At The Cantor Fitzgerald Global Healthcare Conference

LEXINGTON, Mass., Sept.

Curis Announces Leadership Change

Curis Announces Leadership Change

Company Appoints James Dentzer President and CEO

Curis To Present At The Baird 2018 Global Healthcare Conference

Curis To Present At The Baird 2018 Global Healthcare Conference

LEXINGTON, Mass., Aug.

Curis Reports Second Quarter 2018 Financial Results

Curis Reports Second Quarter 2018 Financial Results

-- Management to host conference call today at 8:30 a.m. EDT --

Curis To Release Second Quarter Financial Results And Hold Conference Call On August 2, 2018

Curis To Release Second Quarter Financial Results And Hold Conference Call On August 2, 2018

LEXINGTON, Mass., July 27, 2018 /PRNewswire/ -- Curis, Inc.

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LEXINGTON, Mass., July 9, 2018 /PRNewswire/ -- Curis, Inc.

CRIS: Insiders Vs. Shorts

The most recent short interest data was recently released for the 04/30/2018 settlement date, and Curis Inc is one of the most shorted stocks of the Russell 3000, based on 7.52 "days to cover" versus the median component at 5.00. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Curis Reports Third Quarter 2017 Financial Results

Curis Reports Third Quarter 2017 Financial Results

-- Management to host conference call today at 8:30 a.m. EST --

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr.

Curis Reports Second Quarter 2017 Financial Results

Curis Reports Second Quarter 2017 Financial Results

-- Management to host conference call today at 8:30 a.m. EDT --

Curis Reports First Quarter 2017 Financial Results

-- Management to host conference call today at 8:30 a.m. EDT --

TheStreet Quant Rating: D- (Sell)